GGTLC1 and COVID-19: Furthermore, a retrospective study by Bernal-Monterde et al. (29) showed that elevated levels of gamma-glutamyl transpeptidase and alkaline phosphatase, along with decreased albumin levels, were linked to an increased mortality risk in COVID-19 patients.